His area of interest is exploring the effects of tumor heterogeneity on relapse and resistance to therapies in sarcomas. (ccri.uthscsa.edu)
In a study published in Nature, researchers lead by Cédric Blanpain, MD / PhD, WELBIO investigator and Professor at the Université libre de Bruxelles, Belgium, in collaboration with Pr Wayne Phillips, Australia and Pr Christos Sotiriou, Bordet Institute, Belgium, uncovered the cellular origin of PIK3CA - induced breast tumors and demonstrated that the cancer cell of origin controls tumor heterogeneity and is associated with different breast tumors types and clinical prognosis. (sciencedaily.com)
Carrie Bhang is a research investigator in In Vivo Pharmacology at Novartis Oncology and is particularly interested in applying what we have learned about tumor heterogeneity to drug discovery and the development of combination therapies. (blog.addgene.org)